| KEGG pathway | | Genes |
| Fatty acid elongation | 4.84 | Hadha, Elovl6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 2.94 | Cacng4, Cacna2d1, Sgcd, Jup, Itgb8, Gja1 | Other types of O-glycan biosynthesis | 2.34 | B3glct, Pomt2, Fut9, Colgalt2 | Thyroid hormone synthesis | 2.04 | Duox2, Tg | Tyrosine metabolism | 2.04 | Maoa, Aldh1a3 | Mucin type O-Glycan biosynthesis | 1.76 | Galnt16, Galnt7 | Other glycan degradation | 1.66 | Neu3 | Glycosphingolipid biosynthesis-lacto and neolacto series | 1.66 | B3galt2, Fut9 | Tryptophan metabolism | 1.66 | Afmid, Hadha, Tph2, Maoa, Ogdhl | Gap junction | 1.66 | Tjp1, Egfr, Nras, Grm5, Gja1 | Proteoglycans in cancer | 1.66 | Wnt2, Cttn, Wnt4, Fgfr1, Egfr, Fn1, Nras, Erbb3, Rock2, Flna, Fzd3, Wnt2b, Pik3cd, Cav3, Ppp1cc | Signaling pathways regulating pluripotency of stem cells | 1.57 | Fgfr3, Wnt2, Wnt4, Fgfr1, Nras, Nodal, Smad4, Fzd3, Wnt2b, Pik3cd, Acvr1c |
|
|